Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide

Protein shakes, Greek yogurt, lean meats, and eggs become staples during any aggressive weight management protocol
Another confirmed seeing results instantly: Improved Metabolism The amino acids in lipotropic injections, such as methionine, inositol, and choline, enhance the body's metabolic rate
Consistency is key for fat-metabolism benefits
gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention
Phase Week 2-4 Window Body acclimates What People Report Most early side effects fade